Arc's AI Pivot, Samsung's Medical Leap, and Chime's IPO Countdown
Explore The Browser Company's strategic shift towards AI, Samsung's potential $100M investment in Exo, and Chime's IPO plans. Plus, a deep dive into nuclear fission startups, VW's landmark trial, and the debate on AI training data permissions.
Arc's AI Pivot, Samsung's Medical Leap, and Chime's IPO Countdown
Explore The Browser Company's strategic shift towards AI, Samsung's potential $100M investment in Exo, and Chime's IPO plans. Plus, a deep dive into nuclear fission startups, VW's landmark trial, and the debate on AI training data permissions.